NCT07335939 Late-term Abortions Between 14 and 16 Weeks of Gestation: Comparison of Hemorrhagic Risks in Surgical vs. Medical Abortions
| NCT ID | NCT07335939 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Abortion Late |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-05-19 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-05-19 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Since the extension of the legal abortion limit to 16 weeks by the law of March 2, 2022, we must adapt our care to reduce the risks associated with this procedure. According to the French National Authority for Health (HAS), all abortions after 9 weeks of gestation should be performed surgically, but the French National College of Gynecologists and Obstetricians (CNGOF) indicates that each patient should have the choice of method regardless of the gestational age at the time of the abortion.
Eligibility Criteria
Inclusion Criteria: * Adult woman * Single or multiple pregnancy * Undergoing an abortion between 14 and 16 weeks of gestation at the Strasbourg University Hospital between March 2, 2022, and March 2, 2026 Exclusion Criteria: * Missed Pregnancy * Term \< 14 Weeks of Gestation or \> 16 Weeks of Gestation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07335939 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Abortion Late. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07335939 currently recruiting?
Yes, NCT07335939 is actively recruiting participants. Contact the research team at Victor.gabriele@chru-strasbourg.fr for enrollment information.
Where is the NCT07335939 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07335939 clinical trial?
NCT07335939 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 50 participants.